Dose Considerations Sample Clauses

Dose Considerations. For iodinated contrast studies of the breast, we propose to initially perform a pre-contrast scan and 1 post-contrast scan. Exact timing of the post-contrast scans needs to be explored as part of this study. The average glandular dose to the breast volume per scan will be 4 mGy to 13 mGy per scan (+/-20%), depending on breast size and density or similar to the subject’s diagnostic mammogram. Thus, the dose for a full two-scan protocol will be ~ 8 to 26 mGy, or similar to two diagnostic mammography exams. By comparison, this dose is up to 2-3 times lower than multi-slice CT scans of the breast, which results in a CTDI100 ~12-18 mGy glandular dose/scan. In addition, these multi-slice CT scans radiate the entire thorax in addition to the breast at much higher photon energies (120 kVp compared to 49 kVp). The effective dose from a conventional chest CT scan is 7 mSv, which is equivalent to 2 years of natural background radiation [16]. The effective dose from a two-scan, single breast CE- CBBCT exam is from 0.1.2 mSv to 3.8 mSv, which is equivalent to approximately 4.6 months to 14.7 months of natural background radiation. This conversion is based on a breast tissue weighting factor of 0.15 per NRC 10CFR 20.1003 Definitions. Two scans are typically performed at ~30 seconds and 2 minutes after contrast injection. In addition, 3 mm thick slices are taken to scan the breast volume. At 0.8 sec/rotation and a pitch of 1, it takes ~40 seconds to cover ~150 mm distance to capture the full breast. Contrast enhancement can change significantly during this time. The CBBCT scan, however, takes only 10 seconds to scan a full breast volume thus capturing a volume “snapshot” of the contrast-enhanced tumors at that time.
AutoNDA by SimpleDocs

Related to Dose Considerations

  • Cash Consideration In case of the issuance or sale of additional Shares for cash, the consideration received by the Company therefor shall be deemed to be the amount of cash received by the Company for such Shares (or, if such Shares are offered by the Company for subscription, the subscription price, or, if such Shares are sold to underwriters or dealers for public offering without a subscription offering, the public offering price), without deducting therefrom any compensation or discount paid or allowed to underwriters or dealers or others performing similar services or for any expenses incurred in connection therewith.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!